This overview focuses on the recent developments in the safety and efficacy of the levonorgestrel-releasing intrauterine system (LNG-IUS) on established indications, namely contraception ...

SMIs encompass a large group of molecular therapies including tyrosine kinase inhibitors that target growth receptor signaling, cell cycle regulatory factors and angiogenesis. Growth factors such ...